JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB1927

Mouse monoclonal [2C11] Anti-Human IgG1 Fc

Mouse monoclonal [2C11] Anti-Human IgG1 Fc

5

(1 Review)

|

(14 Publications)

Mouse Anti-Human IgG1 Fc (ab1927) is an unconjugated secondary antibody that is suitable for IHC and ELISA applications.

- Suitable for custom labeling or when non-standard detection methods are required
- Cited in over 10 publications

別名を表示する

Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1

1 Images
ELISA - Mouse monoclonal [2C11] Anti-Human IgG1 Fc (AB1927)
  • ELISA

PubMed

ELISA - Mouse monoclonal [2C11] Anti-Human IgG1 Fc (AB1927)

Characterisation of virus activity and functional expression of monoclonal antibodies.

(Panel B) IgG1 antibody expression detected in cellular supernatants of HT-29 cells infected with 10ppc NG-135 by anti-IgG1 ELISA.

Media was removed from infected or control cells, clarified by centrifugation and diluted 1 in 2 in 3% BSA/PBS for storage at -20°C. For quantification of human IgG1, 96 well plates (NUNC) were coated overnight, 4°C, with mouse monoclonal anti-human IgG1 Fc antibody (ab1927, Abcam) at a 1 : 1000 dilution in carbonate/bicarbonate buffer. Plates were blocked in 3% BSA/PBS, washed and samples and standards added to the plate for 1 hr and RT. Secondary detection was carried out using a HRP conjugated goat anti-human IgG Fab (ab87422, Abcam) incubated for 1 hr, RT.

Marino et al PLoS One. 2017 May 18;12(5):e0177810. doi: 10.1371/journal.pone.0177810. eCollection 2017. Fig 5. Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/

関連する標識済み抗体及び組成の異なる製品 (1)

Key facts

宿主種

Mouse

ターゲット種

Human

ターゲットアイソタイプ

IgG1

ターゲット特異性

Fc region

最小限の交差反応性
血清吸着処理済み

No

アプリケーション

ELISA, IHC-Fr

applications

クローン性

Monoclonal

クローン番号

2C11

アイソタイプ

IgG1

免疫原

Native Full Length Protein corresponding to Human IGHG1.

P01857

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "IHC-Fr": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

製品の詳細

When it comes to advancing your immunohistochemistry (IHC) research, Abcam offers a comprehensive suite of IHC kits and secondary antibodies, designed to deliver precise and reliable results.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
精製に関する特記事項
Chromatography on protein A Sepharose
バッファー組成
pH: 7.4 Preservative: 0.09% Sodium azide Constituents: PBS
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

製品プロトコール

ターゲットの情報

Constant region of immunoglobulin (Ig) heavy chains. Igs are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors, which upon binding to a specific antigen trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs known as antibodies mediate the effector phase of humoral immunity by blocking the interaction of infectious antigens with cellular receptors (via the antigen-binding region) and eliciting effector mechanisms that lead to pathogen neutralization (via the constant region) (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its associated light chain. Each Ig molecule has two antigen-binding sites with remarkable affinity for a particular antigen due to V-(D)-J rearrangement, somatic hypermutations and affinity maturation of the variable domains upon antigen exposure (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region defines the Ig isotype that perform distinct sets of effector functions. B cells diversify and rearrange their Ig constant regions through class-switch recombination, a process by which the constant region is switched from one Ig isotype to another, namely from IgM and IgD to IgG, IgA and IgE (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region of Ig gamma-1 (IgG1) isotype interacts (via the fragment crystallizable, Fc) with receptors on innate immune cells and the complement system to mediate humoral effector functions, including antibody-dependent cellular cytotoxicity or phagocytosis, complement-dependent cytotoxicity and inflammatory responses.
See full target information IGHG1

文献 (14)

Recent publications for all applications. Explore the full list and refine your search

Haematologica 109:3167-3181 PubMed38813729

2024

Single-cell CRISPR screening characterizes transcriptional deregulation in T-cell acute lymphoblastic leukemia.

Applications

Unspecified application

Species

Unspecified reactive species

Sarah Meyers,Olga Gielen,Jan Cools,Sofie Demeyer

Development (Cambridge, England) 150: PubMed37260147

2023

RTK signalling promotes epithelial columnar cell shape and apical junction maintenance in human lung progenitor cells.

Applications

Unspecified application

Species

Unspecified reactive species

Shuyu Liu,Dawei Sun,Richard Butler,Emma L Rawlins

Nature communications 12:4164 PubMed34230493

2021

Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia.

Applications

Unspecified application

Species

Unspecified reactive species

Quentin Van Thillo,Jolien De Bie,Janith A Seneviratne,Sofie Demeyer,Sofia Omari,Anushree Balachandran,Vicki Zhai,Wai L Tam,Bram Sweron,Ellen Geerdens,Olga Gielen,Sarah Provost,Heidi Segers,Nancy Boeckx,Glenn M Marshall,Belamy B Cheung,Kiyotaka Isobe,Itaru Kato,Junko Takita,Timothy G Amos,Ira W Deveson,Hannah McCalmont,Richard B Lock,Ethan P Oxley,Maximilian M Garwood,Ross A Dickins,Anne Uyttebroeck,Daniel R Carter,Jan Cools,Charles E de Bock

Respiratory research 20:194 PubMed31443651

2019

Inhibition of lung cancer cells and Ras/Raf/MEK/ERK signal transduction by ectonucleoside triphosphate phosphohydrolase-7 (ENTPD7).

Applications

Unspecified application

Species

Unspecified reactive species

Zhongwei Wen,Rongfang Jiang,Ying Huang,Zhineng Wen,Dong Rui,Xiaoxiao Liao,Zhougui Ling

Medical science monitor : international medical jo 25:5747-5756 PubMed31374070

2019

Upregulation of Insulin-Like Growth Factor-1 Receptor (IGF-1R) Reverses the Inhibitory Effect of Let-7g-5p on Migration and Invasion of Nasopharyngeal Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Zhecheng Zhao,Jianxue Wen,Lihua Peng,Hanbo Liu

Cancer biology & therapy 20:1223-1233 PubMed31132019

2019

Hematopoietic-substrate-1 associated protein X-1 (HAX-1) regulates liver cancer cells growth, metastasis, and angiogenesis through Akt.

Applications

Unspecified application

Species

Unspecified reactive species

Zhenyu Wu,Xiangnan Ai,Hao Hu,Siqi Wang,Yang Wang,Feng Kang,Caiguo Ouyang,Jiye Zhu

Neoplasma 66:584-592 PubMed31058534

2019

Effects of neuroblastoma breakpoint family member 1 (NBPF1) gene on growth and Akt-p53-Cyclin D pathway in cutaneous squamous carcinoma cells.

Applications

Unspecified application

Species

Unspecified reactive species

Y Gao,H Zhu,Q Mao

Cell cycle (Georgetown, Tex.) 18:425-436 PubMed30700227

2019

Sirtuin 6 overexpression relieves sepsis-induced acute kidney injury by promoting autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Yang Zhang,Ling Wang,Lei Meng,Guangke Cao,Yu Wu

Cancer biology & therapy 20:680-691 PubMed30590988

2018

Krüppel like factor 6 splice variant 1 (KLF6-SV1) overexpression recruits macrophages to participate in lung cancer metastasis by up-regulating TWIST1.

Applications

Unspecified application

Species

Unspecified reactive species

Jian Wang,Xiao Wang,Yawei Wang,Shuguang Li,Xiuwen Wang

Cancer cell 34:271-285.e7 PubMed30107177

2018

Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia.

Applications

Unspecified application

Species

Unspecified reactive species

Marlies Vanden Bempt,Sofie Demeyer,Michaël Broux,Jolien De Bie,Simon Bornschein,Nicole Mentens,Roel Vandepoel,Ellen Geerdens,Enrico Radaelli,Beat C Bornhauser,Andreas E Kulozik,Jules P Meijerink,Jean-Pierre Bourquin,Charles E de Bock,Jan Cools
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com